GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Cash Conversion Cycle

Icecure Medical (Icecure Medical) Cash Conversion Cycle : 226.48 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Icecure Medical's Days Sales Outstanding for the three months ended in Dec. 2023 was 7.67.
Icecure Medical's Days Inventory for the three months ended in Dec. 2023 was 327.29.
Icecure Medical's Days Payable for the three months ended in Dec. 2023 was 108.48.
Therefore, Icecure Medical's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 226.48.


Icecure Medical Cash Conversion Cycle Historical Data

The historical data trend for Icecure Medical's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Cash Conversion Cycle Chart

Icecure Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.50 96.23 164.50 389.58 380.72

Icecure Medical Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 417.92 527.30 406.56 502.90 226.48

Competitive Comparison of Icecure Medical's Cash Conversion Cycle

For the Medical Devices subindustry, Icecure Medical's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icecure Medical's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Cash Conversion Cycle falls into.



Icecure Medical Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Icecure Medical's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=10.23+485.53-115.04
=380.72

Icecure Medical's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=7.67+327.29-108.48
=226.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icecure Medical  (NAS:ICCM) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Icecure Medical Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Icecure Medical (Icecure Medical) Business Description

Traded in Other Exchanges
N/A
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical (Icecure Medical) Headlines

From GuruFocus